Get the Stockscreener App
1.35
7.53%
-0.11
Pre-market:
1.39
0.04
+2.96%
Beyond Air Inc stock is traded at $1.35, with a volume of 648.80K.
It is down -7.53% in the last 24 hours and up +79.47% over the past month.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
See More
Previous Close:
$1.46
Open:
$1.46
24h Volume:
648.80K
Relative Volume:
0.09
Market Cap:
$11.52M
Revenue:
$1.78M
Net Income/Loss:
$-58.35M
P/E Ratio:
-0.8232
EPS:
-1.64
Net Cash Flow:
$-56.66M
1W Performance:
-30.77%
1M Performance:
+79.47%
6M Performance:
-57.81%
1Y Performance:
+237.50%
1-Day Range:
$1.31
$1.5568
1-Week Range:
$1.31
$2.00
52-Week Range:
$0.1521
$4.78
Beyond Air Inc Stock (XAIR) Company Profile
Name
Beyond Air Inc
Sector
Industry
Phone
516-665-8200
Address
900 STEWART AVENUE, GARDEN CITY, NY
Compare XAIR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XAIR
Beyond Air Inc
|
1.35 | 12.46M | 1.78M | -58.35M | -56.66M | -1.64 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-25 | Initiated | D. Boral Capital | Buy |
| Jun-25-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-28-23 | Initiated | Piper Sandler | Overweight |
| Jun-15-23 | Initiated | BTIG Research | Buy |
| Apr-28-21 | Initiated | Truist | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Outperform |
View All
Beyond Air Inc Stock (XAIR) Latest News
Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences - The Manila Times
Beyond Air CEO lines up two investor conference appearances - Stock Titan
Beyond Air, Inc. to Report Q3 Fiscal 2025 Financial Results on February 13, 2026 - Quiver Quantitative
Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and Webcast - The Manila Times
Merger Talk: Will Beyond Air Inc stock benefit from M ADip Buying & High Accuracy Investment Signals - baoquankhu1.vn
Beyond Air Announces $5 Million Private Placement Financing - TipRanks
Short Squeeze: Will Beyond Air Inc stock benefit from M AMarket Trend Report & Daily Volume Surge Signals - baoquankhu1.vn
Can Beyond Air Inc continue delivering strong returnsJuly 2025 Technicals & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Beyond Air (XAIR) Analyst Rating Maintained as Buy at $11.00 by D. Boral Capital | XAIR Stock News - GuruFocus
Exit Recap: Is Beyond Air Inc showing insider buyingTrade Entry Report & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Beyond Air Signs Multiple Material Agreements - TradingView
Published on: 2026-01-20 07:10:21 - baoquankhu1.vn
Buybacks Report: Is NRXP in a consolidation phaseEarnings Performance Report & Free Verified High Yield Trade Plans - baoquankhu1.vn
CEO Change: Does Beyond Air Inc have a competitive edgeQuarterly Market Summary & Verified Momentum Stock Watchlist - baoquankhu1.vn
Beyond Air, Inc. (NASDAQ:XAIR) Short Interest Update - Defense World
Analyst Downgrade: Is Beyond Air Inc stock a buy or sellJuly 2025 Technicals & Free Community Supported Trade Ideas - baoquankhu1.vn
XAIR: Second-generation nitric oxide device and global expansion set to accelerate growth - TradingView — Track All Markets
Market Review: Does Trump Media Technology Group Corp Equity Warrant have a sustainable dividend2025 Price Momentum & Weekly High Conviction Ideas - baoquankhu1.vn
NY-based Beyond Air announces USD 5M private placement - Medical Buyer
Beyond Air, Inc. Announces Sale of NeuroNOS Stake to XTL Biopharmaceuticals - TradingView
Beyond Air’s Nitric Oxide Bet Faces Cash Burn And Dilution - Finimize
Medical Stocks To Watch Now – January 13th - Defense World
Beyond Air secures $5 million in private placement financing By Investing.com - Investing.com Nigeria
Small Cap Stocks To Research – January 13th - Defense World
Penny Stocks To Follow Now – January 13th - Defense World
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), Travere Therapeutics (TVTX) and Beyond Air (XAIR) - The Globe and Mail
Beyond Air, Inc. announced that it expects to receive $5 million in funding - marketscreener.com
XAIR Stock Soars Amid Strategic Market Moves and Financial Adjustments - StocksToTrade
Beyond Air (XAIR) Secures $5M Through Private Placement Deal - GuruFocus
Title: Beyond Air Inc. Navigates Market Dynamics Amid Strategic Announcements - timothysykes.com
Beyond Air secures $5 million in private placement financing - Investing.com
Beyond Air announces $5.0 million private placement priced at-the-market under Nasdaq rules - marketscreener.com
Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - The Manila Times
Press Release: Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - 富途资讯
Beyond Air (XAIR) Stock Soars as Company Sells Autism Drug Platform for $32.5 Million - Blockonomi
Is Beyond Air Inc.’s ROIC above industry averageGrowth Stock Opportunities & Small Capital Portfolio Tips - bollywoodhelpline.com
Beyond Air (XAIR) stock whipsaws after NeuroNOS deal — premarket drop follows 150% rally - TechStock²
Beyond Air (XAIR) Stock Soars 150% on $32M NeuroNOS Subsidiary Sale - CoinCentral
XAIR Stock More Than Doubled TodayWhat's Driving The Rally? - Menafn
Beyond Air Announces $5.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules - TradingView
XAIR Stock More Than Doubled Today — What’s Driving The Rally? - Asianet Newsable
XAIR stock Beyond Air (NASDAQ) $2.22 intraday 13 Jan 2026: XTL deal lifts volume - Meyka
XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS - citybiz
Crypto: XAIR at Critical Level: Why This Week Matters More Than Ever - InteractiveCrypto
Medical Stocks To Watch NowJanuary 13th - MarketBeat
Promising Pharmaceutical Stocks To Add to Your WatchlistJanuary 13th - MarketBeat
Beyond Air Deals Autism-Focused NeuroNOS To XTL For Equity, Future Payments - Benzinga
Beyond Air Stock (XAIR) Opinions on NeuroNOS Acquisition Deal - Quiver Quantitative
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
XLT Biopharma To Acquire 85% Of Beyond Air Subsidiary NeuroNOS In Autism Therapeutics Push; Stock Up - Nasdaq
XTL Biopharmaceuticals to acquire autism therapeutics firm NeuroNOS - Investing.com
Beyond Air Inc Stock (XAIR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
0.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):